IL-18R-dependent and independent pathways account for IL-18-enhanced antitumor ability of CAR-T cells.
Huang Y, Li D, Zhang PF, Liu M, Liang X, Yang X, Jiang L, Zhang LF, Zhou WL, Su JH, Gong YL, Gou HF, Wei YQ, Wang W.
Huang Y, et al. Among authors: zhang pf, zhang lf.
FASEB J. 2020 Jan;34(1):1768-1782. doi: 10.1096/fj.201901809R. Epub 2019 Dec 6.
FASEB J. 2020.
PMID: 31914650